Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
adverse drug reaction
anti MAG antibodies
antibodies to myelin basic protein
antimyelin antibodies
aphasia
asymptomatic
ataxia
axonal degeneration
axonal transection
B cell lymphocytes
Barkhof MR criteria for MS
BCG vaccination
BENEFIT study
brain atrophy
brain volume
brainstem
brainstem, lesion of
carcinoma
carcinoma of breast
catatonia
cerebral cortex
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
cervical spine
children
cigarette smoking
cognition
complications
controversies in neurology
conus medullaris, lesion of
cop 1
corproporphyrins
corpus callosum, lesion of
dementia
demyelinating disease
depression
diabetes insipidus
diagnostic criteria
differential diagnosis
disability rating scale, neurological
disability, neurological
efficacy
electroencephalogram
electroencephalogram, abnormalities of
epidemiology of neurology
Epstein-Barr virus
ethics in neurology
evoked potentials
extinction on double simultaneous stimulation
flu-like illness
fourth ventricle, shift of
gadolinium
gammaglobulin therapy, intravenous
hearing loss
hearing loss, sudden, unilateral
heralding manifestation
herpes virus
herpes virus infection
hydrocephalus
hydrocephalus, exvacuo
immunomodulation
immunosuppressive agents
infection
intellectual deficit
intellectual deterioration
interferon
interferon beta 1-a
interferon beta 1-b
intravenous
laquinimod
leg weakness, unilateral
leukopenia
liver function enzymes
mania
manic-depressive
McDonald criteria for MS
memory, impairment of
mimics
misdiagnosis
mitoxantrone
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength
MRI, field strength, high
MRI, incidental finding
MRI, lesion burden
MRI, negative
MRI, optic nerve
MRI, serial
MRI, spinal cord
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, asymptomatic
multiple sclerosis, benign form of
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, cognitive presenttion
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, early onset
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
N-acetyl-L-aspartic acid
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathology
neuroprotective agents
neuropsychiatry
ocrelizumab
optic nerve, lesion of
optic neuritis
optic neuritis, bilateral
optic neuritis, children
optic neuritis, etiology of
optic neuritis, recurrent
optic neuritis, treatment of
optical coherence tomography
periventricular leukomalacia
placebo
posterior fossa
posterior fossa, lesion of
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
protein 14-3-3, cerebrospinal fluid
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
radiculitis
radiculopathy
review article
risk factors
root lesion, nerve
rubeola virus
safety
seizure
seizure, children
seizure, non-treatment of
seizure, treatment of
seizure, treatment of, first
sensorineural hearing loss
serologic testing
spinal cord
spinal cord, cervical
spinal cord, lesion of
status epilepticus
steroid
steroid therapy, CNS treatment and complications with
symmetric brain lesions
symptomatic
tinnitus
treatment of neurologic disorder
ventricular enlargement
viral infection
viral infection, reactivation
visual evoked response
white matter disease
white matter disease, periventricular
workup
Showing articles 1250 to 1300 of 6244 << Previous Next >>

Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995

Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995

Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995

Trigeminal Neuralgia in Multiple Sclerosis
Neurol 45:1294-1296, Hooge,J.P.&Redekop,W.K., 1995

Association Between Trigeminal Neuralgia and Multiple Sclerosis:Role of Magnetic Resonance Imaging
JNNP 59:253-259, Meaney,J.F.M.,et al, 1995

Risk of Recurrent Stroke in Patients with Sickle Cell Disease Treated with Erythrocyte Transfusions
J Pediatr 126:896-899, Pegelow,C.H.,et al, 1995

Reflex Sympathetic Dystrophy
BMJ 310:1645-1648, Paice,E., 1995

Recurrent Stroke and Thrombo-Occlusive Events in the Antiphospholipid Syndrome
Ann Neurol 38:119-124, Levine,S.R.,et al, 1995

Neurofibromatosis 1 and Multiple Sclerosis
JNNP 58:582-585, Ferner,R.E.,et al, 1995

Identification of Comatose Patients at High Risk for Death or Severe Disability
JAMA 273:1842-1848, Hamel,M.B.,et al, 1995

Mitral Valve Prolapse and the Risk of Stroke After Initial Cerebral Ischemia
Neurol 45:1083-1086, Orencia,A.J.,et al, 1995

Frequency of Anti-Nuclear Antibodies in Multiple Sclerosis
Neurol 45:384-385, Barned,S.,et al, 1995

Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995

Decreased Hippocampal Volume Asymmetry on MRIs in Nondemented Elderly Subjects Carrying the Apolipoprotein E-4 Allele
Neurol 45:391-392, Soininen,H.,et al, 1995

The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995

New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995

Tourette's Syndrome:A Model Neuropsychiatric Disorder
JAMA 273:498-501, Hyde,T.M.&Weinberger,D.R., 1995

Acute Viral Encephalitis in Childhood
BMJ 310:139-140, Kennedy,C., 1995

Bilateral Simultaneous Optic Neuropathy in Adults:Clinical, Imaging, Serological, and Genetic Studies
JNNP 58:70-74, Morrissey,S.P.,et al, 1995

Optic Neuritis:A Population-Based Study in Olmsted County, Minnesota
Neurol 45:244-250, Rodriquez,M.,et al, 1995

Clinical, Neurodiagnostic, and MR Findings in Children with Spinal & Brain Stem Multiple Sclerosis
AJNR 16:87-95, Glasier,C.M.,et al, 1995

Prediction of Long-Term Outcome in the Early Hours Following Acute Ischemic Stroke
Arch Neurol 52:250-255, Fiorelli,M.,et al, 1995

Acute Bilateral Cerebellar Infarction in the Territory of the Medial Branches of Posterior Inferior Cerebellar Arteries
Stroke 25:686-688, Yoshimasa,T.,et al, 1994

Imaging in Acute Basilar Artery Thrombosis
Neuroradiology 36:426-429, Castillo,M.,et al, 1994

The Hidden Costs of Medicolegal Abuses in Neurology
Arch Neurol 51:650-652, Scheinberg,P., 1994

Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994

A Double-Blind, Placebo-Controlled Trial of Tizanidine in the Treatment of Spasticity Caused by Multiple Sclerosis
Neurol 44:S70-S78, Barnes,M.P.,et al, 1994

High Prevalence of Antiphospholipid Antibodies in Children with Idiopathic Cerebral Ischemia
Pediatrics 94:500-503, Angelini,L.,et al, 1994

A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
Arch Neurol 51:1245-1252, Jacobs,L.&Johnson,K.P., 1994

Regional Brain Abnormalities in Schizophrenia Measured with Magnetic Resonance Imaging
JAMA 272:1763-1769, Andreasen,N.C.,et al, 1994

Longitudinal MRI in Multiple Sclerosis:Correlation Between Disability and Lesion Burden
Neurol 44:2120-2124, Khoury,S.J.,et al, 1994

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

Posttraumatic Headache
Semin Neurol 14:40-45, Packard,R.C., 1994

Mild Head Injury
(Ed) , Semin Neurol 14:1-9294., Packard,R.C., 1994

Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutations in Multiple Sclerosis
Ann Neurol 36:109-112, Kellar-Wood,H.,et al, 1994

Uhthoff's Symptom in Disorders of the Anterior Visual Pathways
Neurol 44:1036-1038, Lepore,F.E., 1994

MR of Sarcoidosis in the Head and Spine:Spectrum of Manifestations and Radiographic Response to Steroid Therapy
AJNR 15:973-982, Lexa,F.J.&Grossman,R.I., 1994

Orbital and Optic Pathway Sarcoidosis:MR Findings
AJNR 15:775-783, Carmody,R.F.,et al, 1994

Neuroanatomy of Fragile X Syndrome:The Temporal Lobe
Neurol 44:1317-1324, Reiss,A.L.,et al, 1994

Reduced Basal Ganglia Volume Associated with the Gene for Huntington's Disease in Asymptomatic at-Risk Persons
Neurol 44:823-828, Aylward,E.H.,et al, 1994

The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol 51:505-516, Goodkin,D.E.,et al, 1994

Benign Form of Multiple Sclerosis:MRI Evidence for Less Frequent and Less Inflammatory Disease Activity
JNNP 57:1070-1072, Kidd,D.,et al, 1994

Quantitative Brain MRI Lesion Load Predicts the Course of Clinically Isolated Syndromes Suggestive of Multiple Sclerosis
Neurol 44:635-641, Felippi,M.,et al, 1994

Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome after Supratentorial Hemorrhagic Stroke
Stroke 25:1207-1210, Fukui,K.,et al, 1994

Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994

Cerebrospinal Fluid in the Diagnosis of Multiple Sclerosis:A consensus Report
JNNP 57:897-902, Andersson,M.,et al, 1994

Prognosis of Young Adults with Ischemic Stroke:Follow-up Assessing Recurrent Vascular Events & Funct Outcome
Stroke 25:1360-1365, Kappelle,L.J.,et al, 1994

Interrater Agreement in Evaluation of Stroke Patients with the Unified Neurological Stroke Scale
Stroke 25:1263-1264, Treves,T.A.,et al, 1994

Deep Gray Matter Involvement in Children with Acute Disseminated Encephalomyelitis
AJNR 15:1275-1283, Baum,P.A.,et al, 1994

Breast Feeding and Multiple Sclerosis
BMJ 308:1411-1412, Pisacane,A.,et al, 1994



Showing articles 1250 to 1300 of 6244 << Previous Next >>